XOLAIR Side Effects

6974630-7 | Burning Sensation, Flushing, Pruritus
on Aug 11, 2010 Female patient from UNITED STATES , weighting 211.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: burning sensation, flushing, pruritus. Xolair dosage: 225 Mg, Q2w. During the same period patient was treated with PATANASE (View Patanase Review and Patanase Label ), SINGULAIR (View Singulair Review and Singulair Label ), ZEGERID (View Zegerid Review and Zegerid Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), XOPENEX HFA (View Xopenex Hfa Review and Xopenex Hfa Label ), EFFEXOR (View Effexor Review and Effexor Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), CLARITIN (View Claritin Review and Claritin Label ).

6971771-5 | Idiopathic Thrombocytopenic Purpura
Patient was taking Xolair (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura on Aug 27, 2010 from SWITZERLAND Additional patient health information: Female patient , 42 years of age, . Xolair dosage: 300 Mg, 1/month.

6971756-9 | Caesarean Section, Normal Newborn
Adverse event was reported on Aug 27, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 375 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 154.3 lb, After Xolair was administered, patient had the following side effects: caesarean section, normal newborn. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), BETAMETHASONE SODIUM PHOSPHATE (Unk) (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ).

6971754-5 | Anaphylactic Reaction
on Aug 31, 2010 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Xolair dosage: 375 Mg, Q2w. Patient was hospitalized.


6971753-3 | Deep Vein Thrombosis
on Aug 27, 2010 Male patient from SWITZERLAND , 63 years of age, weighting 264.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Xolair dosage: Unk. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), LIRAGLUTIDE (View Liraglutide Review and Liraglutide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ).

6971723-5 | Asthma
Patient was taking Xolair (View Usage). After Xolair was administered, patient had the following side effects: asthma (What is asthma?) on Aug 27, 2010 from SWITZERLAND Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 225 Mg, Q2w. During the same period patient was treated with PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ), SEREVENT (Unk) (View Serevent Review and Serevent Label ), PRANLUKAST HYDRATE (Unk) (View Pranlukast Hydrate Review and Pranlukast Hydrate Label ), THEOPHYLLINE (Unk) (View Theophylline Review and Theophylline Label ), ALBUTEROL SULFATE AUTOHALER (Unk) (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6971545-5 | Asthma
Adverse event was reported on Aug 31, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 375 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 235.5 lb, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALLEGRA D 24 HOUR (View Allegra D 24 Hour Review and Allegra D 24 Hour Label ), NASONEX (View Nasonex Review and Nasonex Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ).

6969490-4 | Acute Myocardial Infarction, Cough
on Aug 24, 2010 Male patient from SWITZERLAND , weighting 195.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: acute myocardial infarction, cough. Xolair dosage: 450 Mg, Qd. During the same period patient was treated with AIROMIR (Unk) (View Airomir Review and Airomir Label ), SERETIDE (Unk) (View Seretide Review and Seretide Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCICHEW D3 (Unk) (View Calcichew D3 Review and Calcichew D3 Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), FLUOXETINE (Unk) (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6969481-3 | Allergic Granulomatous Angiitis, Cerebrovascular Accident, Dyspnoea, Sinusitis, Tunnel Vision, Vasculitis
on Aug 31, 2010 Male patient from UNITED STATES , weighting 212.0 lb, was diagnosed with asthma (What is asthma?), pneumonia (What is pneumonia?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: allergic granulomatous angiitis, cerebrovascular accident, dyspnoea, sinusitis (What is sinusitis?), tunnel vision, vasculitis (What is vasculitis?). Xolair dosage: Unk. Patient was hospitalized.

6969345-5 | Asthma, Asthmatic Crisis, Dyspnoea, Hypersensitivity, Nasal Congestion, Sneezing, Wheezing
Patient was taking Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), asthmatic crisis, dyspnoea, hypersensitivity, nasal congestion, sneezing, wheezing on Aug 24, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 140.9 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 300 Mg, 1/month.

6968556-2 | Injection Site Haematoma, Urticaria
Adverse event was reported on Aug 30, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Mg, 1/month) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 165.0 lb, Patient had the following side effects: injection site haematoma, urticaria.

6966321-3 | Asthma, Fatigue, Influenza Like Illness, Injection Site Erythema, Injection Site Induration, Injection Site Pain, Myalgia
on Aug 23, 2010 Female patient from SWITZERLAND , weighting 110.2 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: asthma (What is asthma?), fatigue, influenza like illness, injection site erythema, injection site induration, injection site pain, myalgia. Xolair dosage: 375 Mg, Q2w. During the same period patient was treated with ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), THEO DUR (Unk) (View Theo-dur Review and Theo-dur Label ), UNIPHYL (Unk) (View Uniphyl Review and Uniphyl Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MAGMITT (View Magmitt Review and Magmitt Label ), PROMAC (JAPAN) (View Promac (japan) Review and Promac (japan) Label ). Patient was hospitalized.

6966298-0 | Dizziness, Syncope
on Aug 23, 2010 Male patient from SWITZERLAND , child 10 years of age, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), syncope. Xolair dosage: 150 Mg, 1/month.

6963970-3 | Chest Discomfort, Dyspnoea, Hypersensitivity
Patient was taking Xolair (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, hypersensitivity on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 179.0 lb, was diagnosed with asthma (What is asthma?), dyspnoea, hypersensitivity, bronchitis (What is bronchitis?), gastrooesophageal reflux disease and. Xolair dosage: 225 Mg, Q2w. During the same period patient was treated with ALBUTEROL (2 Puff, Prn) (View Albuterol Review and Albuterol Label ), EPIPEN (0.3 A?g, Prn) (View Epipen Review and Epipen Label ), FLONASE (0.05 Unk, Prn) (View Flonase Review and Flonase Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), PREDNISONE (5 Mg, Qd) (View Prednisone Review and Prednisone Label ), PRILOSEC (20 Mg, Qd) (View Prilosec Review and Prilosec Label ), SINGULAIR (10 Mg, Qd) (View Singulair Review and Singulair Label ). Patient was hospitalized.

6963507-9 | Cough, Dyspnoea, Hearing Impaired, Increased Upper Airway Secretion, Malaise, Nasopharyngitis, Pneumonia, Sinusitis, Sputum Discoloured
Adverse event was reported on Aug 20, 2010 by a Male patient taking Xolair (View Usage) (Dosage: 225 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 166.9 lb, After Xolair was administered, patient had the following side effects: cough, dyspnoea, hearing impaired, increased upper airway secretion, malaise, nasopharyngitis, pneumonia (What is pneumonia?), sinusitis (What is sinusitis?), sputum discoloured. During the same period patient was treated with SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), ALVESCO (Unk) (View Alvesco Review and Alvesco Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ).

6963493-1 | Adenovirus Infection, Asthma, Conjunctivitis, Nasal Congestion, Obstructive Airways Disorder, Sinus Congestion, Sinusitis, Wheezing
on Jun 01, 2010 Female patient from SWITZERLAND , weighting 142.2 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: adenovirus infection, asthma (What is asthma?), conjunctivitis, nasal congestion, obstructive airways disorder, sinus congestion, sinusitis (What is sinusitis?), wheezing. Xolair dosage: 300 Mg, 1/month.

6961759-2 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Asthma, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Dermatitis Contact, Diarrhoea, Gamma-glutamyltransferase Increased
on Aug 20, 2010 Male patient from SWITZERLAND , weighting 231.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, asthma (What is asthma?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, dermatitis contact, diarrhoea, gamma-glutamyltransferase increased. Xolair dosage: 300 Mg, 1/month. During the same period patient was treated with MEDROL (24 Mg, Qd) (View Medrol Review and Medrol Label ). Patient was hospitalized.

6961632-X | Anaphylactic Reaction
Patient was taking Xolair (View Usage). After Xolair was administered, patient had the following side effects: anaphylactic reaction on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with PREDNISONE (20 Mg, Unk) (View Prednisone Review and Prednisone Label ), SYNTHROID (.5 A?g, Qd) (View Synthroid Review and Synthroid Label ), ADVAIR DISKUS 100/50 (2 Puff, Bid) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6961598-2 | Acute Respiratory Failure, Acute Sinusitis, Bradyphrenia, Cardiac Arrest, Coma, Haemolytic Anaemia, Sleep Apnoea Syndrome, Status Epilepticus, Thrombocytopenic Purpura
Adverse event was reported on Aug 19, 2010 by a Male patient taking Xolair (View Usage) (Dosage: ) . Location: SWITZERLAND , 45 years of age, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, acute sinusitis, bradyphrenia, cardiac arrest (What is cardiac arrest?), coma, haemolytic anaemia, sleep apnoea syndrome, status epilepticus, thrombocytopenic purpura. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), CETIRIZINA (View Cetirizina Review and Cetirizina Label ). Patient was hospitalized.

6961113-3 | Asthma, Headache
on Aug 19, 2010 Male patient from SWITZERLAND , weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: asthma (What is asthma?), headache (What is headache?). Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with ADVAIR DISKUS 100/50 (1000 A?g, Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), SINGULAIR (10 Mg, Unk) (View Singulair Review and Singulair Label ), THEO DUR (400 Mg, Unk) (View Theo-dur Review and Theo-dur Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6959318-0 | Influenza, Rheumatoid Arthritis, Sinusitis
on Aug 18, 2010 Female patient from SWITZERLAND , weighting 339.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: influenza, rheumatoid arthritis (What is rheumatoid arthritis?), sinusitis (What is sinusitis?). Xolair dosage: 375 Mg, Q2w.

6958221-X | Hepatitis Acute
Patient was taking Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 212.0 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 375 Mg, Q2w. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), SINGULAIR (10 Mg, Unk) (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), NASONEX (Unk) (View Nasonex Review and Nasonex Label ). Patient was hospitalized.

6957019-6 | Pulmonary Embolism
Adverse event was reported on Aug 27, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Mg Every 2 Weeks Sq) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 71 years of age, weighting 177.9 lb, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?).

6956918-9 | Asthma, Otitis Media
on Aug 18, 2010 Female patient from SWITZERLAND , weighting 112.4 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: asthma (What is asthma?), otitis media. Xolair dosage: 300 Mg, 1/month. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ). Patient was hospitalized.

6955930-3 | Congestive Cardiomyopathy
on Aug 26, 2010 Male patient from UNITED STATES , weighting 191.4 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: congestive cardiomyopathy. Xolair dosage: 375mg Q2weeks Sq. During the same period patient was treated with ADVAIR DISKUS FLUTICASONE/SALMETEROL (View Advair Diskus -fluticasone/salmeterol- Review and Advair Diskus -fluticasone/salmeterol- Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), NEBS (View Nebs Review and Nebs Label ), NASONEX MOMETASONE NASAL SPRAY (View Nasonex -mometasone- Nasal Spray Review and Nasonex -mometasone- Nasal Spray Label ).

6946296-3 | Anaphylactic Reaction, Arthralgia, Ear Pain, Headache, Influenza, Lymphadenopathy, Pain Of Skin
Patient was taking Xolair (View Usage). Patient had the following side effects: anaphylactic reaction, arthralgia, ear pain, headache (What is headache?), influenza, lymphadenopathy, pain of skin on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with PREDNISONE (20 Mg, Unk) (View Prednisone Review and Prednisone Label ), SYNTHROID (.5 A?g, Qd) (View Synthroid Review and Synthroid Label ), ADVAIR DISKUS 100/50 (2 Puff, Bid) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6946259-8 | Anxiety, Blood Pressure Systolic Increased, Cyanosis, Dyspnoea, Eye Pain, Headache, Hypersensitivity, Oedema, Oedema Peripheral
Adverse event was reported on Aug 17, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 450 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 209.9 lb, After Xolair was administered, patient had the following side effects: anxiety (What is anxiety?), blood pressure systolic increased, cyanosis, dyspnoea, eye pain, headache (What is headache?), hypersensitivity, oedema, oedema peripheral.

6946221-5 | Angioedema, Eyelid Oedema, Local Swelling, Oedema Peripheral
on Aug 17, 2010 Male patient from SWITZERLAND , weighting 286.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, eyelid oedema, local swelling, oedema peripheral. Xolair dosage: 300 Mg, Unk. During the same period patient was treated with H1N1 VACCINE (Unk) (View H1n1 Vaccine Review and H1n1 Vaccine Label ). Patient was hospitalized.

6945812-5 | Asthma, Injection Site Pain
on Aug 16, 2010 Male patient from SWITZERLAND , weighting 158.7 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: asthma (What is asthma?), injection site pain. Xolair dosage: 375 Mg, Q2w. During the same period patient was treated with MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6943605-6 | Anaphylactic Shock, Myocardial Infarction, Pulmonary Embolism, Thrombosis
Patient was taking Xolair (View Usage). After Xolair was administered, patient had the following side effects: anaphylactic shock, myocardial infarction, pulmonary embolism (What is pulmonary embolism?), thrombosis on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.4 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: Unk. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), XOPENEX (View Xopenex Review and Xopenex Label ), XYZAL (View Xyzal Review and Xyzal Label ). Patient was hospitalized.

6942928-4 | Dyspnoea, Rash, Swelling, Wheezing
Adverse event was reported on Aug 11, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Mg, 1/month) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 226.0 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, rash (What is rash?), swelling, wheezing. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), NEBULIZER TREATMENT (UNK INGREDIENTS) (View Nebulizer Treatment (unk Ingredients) Review and Nebulizer Treatment (unk Ingredients) Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), SINGULAIR (View Singulair Review and Singulair Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6942879-5 | Urticaria
on Aug 11, 2010 Female patient from SWITZERLAND , weighting 92.59 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: urticaria. Xolair dosage: 150 Mg, Unk. During the same period patient was treated with SINGULAIR (10 Mg, Unk) (View Singulair Review and Singulair Label ), SERETIDE (Unk) (View Seretide Review and Seretide Label ).

6942872-2 | Caesarean Section, Premature Labour
on Aug 12, 2010 Female patient from SWITZERLAND , weighting 235.9 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: caesarean section, premature labour. Xolair dosage: 300 Mg, Q2w.

6942867-9 | Premature Baby, Respiratory Distress
Patient was taking Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby, respiratory distress on Aug 12, 2010 from SWITZERLAND Additional patient health information: Male patient , weighting 14.10 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: Unk.

6941658-2 | Deep Vein Thrombosis, Pulmonary Embolism
Adverse event was reported on Aug 20, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 176.4 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6941518-7 | Cardiac Disorder, Condition Aggravated
on Aug 13, 2010 Female patient from SWITZERLAND , 21 years of age, was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: cardiac disorder, condition aggravated. Xolair dosage: .

6941513-8 | Dizziness, Joint Sprain, Musculoskeletal Pain, Vision Blurred
on Aug 13, 2010 Female patient from SWITZERLAND , 40 years of age, was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), joint sprain, musculoskeletal pain, vision blurred. Xolair dosage: 150 Mg, Unk.

6939465-X | Dyspnoea, Pharyngeal Oedema, Pruritus
Patient was taking Xolair (View Usage). Patient had the following side effects: dyspnoea, pharyngeal oedema, pruritus on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 144.0 lb, was diagnosed with asthma (What is asthma?), rhinitis and. Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLOVENT (View Flovent Review and Flovent Label ), RHINOCORT (View Rhinocort Review and Rhinocort Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), LORATADINE (10 Mg, Qd) (View Loratadine Review and Loratadine Label ).

6939430-2 | Erosive Oesophagitis, Gastrointestinal Haemorrhage, Oesophageal Rupture, Oesophageal Ulcer, Reflux Oesophagitis
Adverse event was reported on Aug 11, 2010 by a Male patient taking Xolair (View Usage) (Dosage: 225 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 230.4 lb, After Xolair was administered, patient had the following side effects: erosive oesophagitis, gastrointestinal haemorrhage, oesophageal rupture, oesophageal ulcer, reflux oesophagitis. During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6939376-X | Asthenia, Dizziness, Dry Mouth, Fatigue, Heart Rate Decreased, Hypotension, Lethargy, Liver Function Test Abnormal, Muscle Tightness
on Aug 16, 2010 Female patient from UNITED STATES , weighting 118.1 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), dry mouth, fatigue, heart rate decreased, hypotension, lethargy, liver function test abnormal, muscle tightness. Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with TRAZODONE HCL (100 Mg, Qhs) (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6939338-2 | Cardiac Failure Congestive
on Aug 16, 2010 Female patient from UNITED STATES , weighting 168.0 lb, was treated with Xolair (View Usage). Patient had the following side effects: cardiac failure congestive. Xolair dosage: 300 Mg, Q2w.

6938827-4 | Myocardial Infarction
Patient was taking Xolair (View Usage). After Xolair was administered, patient had the following side effects: myocardial infarction on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, was diagnosed with asthma (What is asthma?) and. Xolair dosage: .

6934748-1 | Anaphylactoid Reaction, Dyspnoea, Headache, Lymphadenopathy, Pruritus, Wheezing
Adverse event was reported on Aug 13, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Mg, Q2w) . Location: UNITED STATES , weighting 142.0 lb, Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, dyspnoea, headache (What is headache?), lymphadenopathy, pruritus, wheezing. During the same period patient was treated with ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), SYNTHROID (0.5 A?g, Unk) (View Synthroid Review and Synthroid Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6934574-3 | Autoimmune Thrombocytopenia
on Aug 06, 2010 Female patient from SWITZERLAND , 14 years of age, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). Patient had the following side effects: autoimmune thrombocytopenia. Xolair dosage: 450 Mg, Unk. Patient was hospitalized.

6930595-5 | Dyspnoea, Nasal Polyps, Nasopharyngitis, Upper Respiratory Tract Infection
on Aug 04, 2010 Male patient from SWITZERLAND , weighting 209.4 lb, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: dyspnoea, nasal polyps, nasopharyngitis, upper respiratory tract infection. Xolair dosage: 375 Mg, Unk.

6928522-X | Cough, Dyspnoea
Patient was taking Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea on Aug 03, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with asthma (What is asthma?) and. Xolair dosage: 300 Mg, Q2w. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), PHYLLOCONTIN (Unk) (View Phyllocontin Review and Phyllocontin Label ), ERYTHROMYCIN (Unk) (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6928459-6 | Blood Pressure Systolic Increased, Dyspnoea, Heart Rate Increased, Hypersensitivity, Increased Upper Airway Secretion, Influenza, Pneumonia, Respiratory Disorder, Sputum Discoloured
Adverse event was reported on Aug 05, 2010 by a Female patient taking Xolair (View Usage) (Dosage: 300 Unk, Unk) was diagnosed with asthma (What is asthma?), hypersensitivity and. Location: SWITZERLAND , weighting 194.0 lb, Patient had the following side effects: blood pressure systolic increased, dyspnoea, heart rate increased, hypersensitivity, increased upper airway secretion, influenza, pneumonia (What is pneumonia?), respiratory disorder, sputum discoloured. During the same period patient was treated with ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), SINGULAIR (View Singulair Review and Singulair Label ), ANTIHISTAMINE NOS (View Antihistamine Nos Review and Antihistamine Nos Label ).

6926479-9 | Arthralgia, Back Pain, Condition Aggravated, Musculoskeletal Pain, Myalgia, Oedema Peripheral, Pain In Extremity
on Aug 02, 2010 Female patient from SWITZERLAND , 55 years of age, was diagnosed with asthma (What is asthma?) and was treated with Xolair (View Usage). After Xolair was administered, patient had the following side effects: arthralgia, back pain (What is back pain?), condition aggravated, musculoskeletal pain, myalgia, oedema peripheral, pain in extremity. Xolair dosage: 300 Mg, 1/month. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLUTICASONE PROPIONATE/SALMETEROL (View Fluticasone Propionate/salmeterol Review and Fluticasone Propionate/salmeterol Label ).

6926349-6 | Allergic Granulomatous Angiitis, Cerebrovascular Accident, Dyspnoea, Sinusitis, Tunnel Vision, Vasculitis
on Aug 10, 2010 Male patient from UNITED STATES , weighting 212.0 lb, was diagnosed with asthma (What is asthma?), pneumonia (What is pneumonia?) and was treated with Xolair (View Usage). Patient experienced the following unwanted or unexpected effects: allergic granulomatous angiitis, cerebrovascular accident, dyspnoea, sinusitis (What is sinusitis?), tunnel vision, vasculitis (What is vasculitis?). Xolair dosage: Unk. Patient was hospitalized.

6926269-7 | Anaphylactic Reaction
Patient was taking Xolair (View Usage). Patient had the following side effects: anaphylactic reaction on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 236.6 lb, was diagnosed with asthma (What is asthma?), hypersensitivity, chronic obstructive pulmonary disease, thyroid disorder and. Xolair dosage: 300 Mg, Q4w. During the same period patient was treated with CLARITIN (Unk) (View Claritin Review and Claritin Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.